In the present society, everyone has their own different lives, people in this society on the pace of life is not the same, some people love it, some people like that kind of life.
Each person’s physique is not the same, so everyone is not the same severity of illness, then select Disease by medical and biological will be different, some people would choose
medical equipment, and some will choose another.
NDRC and the Ministry of Health recently issued a document to carry out reforms by way of pilot fees disease, and diseases for the selection of over 104 references. Charges have been carried out by the pilot disease areas can be combined with national publication of the 104 diseases and gradually expand the scope of the experiment; not yet carried out a medical equipment pilot area, 104 diseases in the selection part of the disease in the pilot. Main points: 1, according to the cost of disease accounting services, including hospital patients from diagnosis to treatment standards at the hospital expenses incurred, in principle, be in charge fees disease; 2, co-workers by improving disease parameters reimbursement payment system.
Smaller short-term impact on listed companies. Disease by the beginning of health reform from the new fees have been proposed, and the pilot started in some areas. Ministry of Health announced last year, more than the clinical path of disease, and this year launched a comprehensive pilot charged by disease is within expectations.
We believe that less short-term impact: 1, the pilot is not mandatory, and the price-making power over to local Development and Reform Commission; 2,104 a disease most likely diagnosis for the surgery, so little effect on drug use ; 3, hemodialysis, heart stent surgery, orthopedic surgery although some diseases among the 104, but before the pilot situation, import and domestic supplies, equipment is still priced separately, so by charging for disease short-term promotion of the role of import substitution is limited; the long term, if the disease by implementation of charges at hospitals, and extended to more diseases, we think of is: 1, long-term help to the use of dialysis supplies and import substitution, good Weigao shares.
However, we think the physical is not the same, for example, some people liked
medical, but some people will choose Disease by medical and biological, although Enhance product not very good, but some people will choose.
In 2010 the company achieved operating income of 88,390.10 million, an increase of 64.33%. First half of the company achieved net profit attributable to shareholders of listed companies 16,088.24 million, an increase of 60.01%, profit after deducting non-recurring net profit attributable to shareholders of listed companies 15,179.30 million, an increase of 59.54%; diluted basic earnings per share 0.63 yuan / shares. Company intends to present the total share capital of 25,558 million as the base, to equity shares for every 10 shares 6 shares.
Data released soon end the broader market retracement of the digestion pressure of 4 main stock index rose for A shares tend to notice performance leather tap investment opportunities in perspective three death squads "Sword" six shares (list) [microblogging] the concept of cloud computing is definitely not a cloud [stock it] break This point can be rest assured to buy shares [and News to know] what the cloud computing concept stocks?
First, the income to maintain a rapid growth, strong performance overseas operations during the reporting period the company achieved operating income of 88,390.10 million, an increase of 64.33%; which rehabilitation products operating income 49,423.51 million, an increase of 46.81%; medical oxygen products to achieve Revenue 25,307.57 million, an increase of 90.56%; medical clinic products operating income 13,457.04 million, an increase of 102.04%.
With the lifting of the ban wheelchairs overseas sales, the company actively exploring overseas markets, the growth of overseas business performance eye-catching. 2010 the company achieved operating income of overseas business 9,849.33 million, an increase of 99.12%, the company’s various products have passed international certification, the company will accelerate the construction of the future system of international marketing, overseas business revenue will be an important growth engine.
However, as some people, then,
things to do in shanghai than Disease by medical and biological better than many, many, as opposed to the words of these two is there are still many people choose to Enhance product’s
Disease by medical and biological and Enhance prod
Linear Mode
